Global Arthralgia Treatment market size is predicted to grow from US$ 7431 million in 2025 to US$ 12770 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

Global Arthralgia Treatment Market Size, Share and Analysis

The global Arthralgia Treatment market size is predicted to grow from US$ 7431 million in 2025 to US$ 12770 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031. Arthralgia describes joint stiffness. Among its many causes are overuse, sprains, injury, gout, tendonitis and a number of infectious diseases, including rheumatic fever and chickenpox. Many people are becoming more aware of the importance of joint health and are taking proactive steps to manage joint pain. This includes regular exercise, a healthy diet, and the use of arthralgia management products such as supplements, pain relievers, and topical creams. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Arthralgia Treatment Industry Forecast looks at past sales and reviews total world Arthralgia Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Arthralgia Treatment sales for 2025 through 2031. With Arthralgia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Arthralgia Treatment industry. This Insight Report provides a comprehensive analysis of the global Arthralgia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Arthralgia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Arthralgia Treatment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Arthralgia Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Arthralgia Treatment. This report presents a comprehensive overview, market shares, and growth opportunities of Arthralgia Treatment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; NSAID &nbsp;&nbsp;&nbsp; Corticosteroids &nbsp;&nbsp;&nbsp; Antidepressants &nbsp;&nbsp;&nbsp; Anticonvulsants &nbsp;&nbsp;&nbsp; Antibiotics Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital Pharmacy &nbsp;&nbsp;&nbsp; Retail Pharmacy &nbsp;&nbsp;&nbsp; Online Pharmacy This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer Inc. &nbsp;&nbsp;&nbsp; GSK Plc &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Mylan N.V. &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries Ltd. &nbsp;&nbsp;&nbsp; Sanofi S.A &nbsp;&nbsp;&nbsp; Boehringer Ingelheim International GmbH &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Johnson & Johnson Private Limited &nbsp;&nbsp;&nbsp; Merck & Co., Inc. &nbsp;&nbsp;&nbsp; Hoffmann-La Roche Ltd. &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company Key Questions Addressed in this Report What is the 10-year outlook for the global Arthralgia Treatment market? What factors are driving Arthralgia Treatment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Arthralgia Treatment market opportunities vary by end market size? How does Arthralgia Treatment break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Arthralgia Treatment Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Arthralgia Treatment by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Arthralgia Treatment by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Arthralgia Treatment Segment by Type &nbsp;2.2.1 NSAID &nbsp;2.2.2 Corticosteroids &nbsp;2.2.3 Antidepressants &nbsp;2.2.4 Anticonvulsants &nbsp;2.2.5 Antibiotics &nbsp;2.3 Arthralgia Treatment Sales by Type &nbsp;2.3.1 Global Arthralgia Treatment Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Arthralgia Treatment Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Arthralgia Treatment Sale Price by Type (2020-2025) &nbsp;2.4 Arthralgia Treatment Segment by Application &nbsp;2.4.1 Hospital Pharmacy &nbsp;2.4.2 Retail Pharmacy &nbsp;2.4.3 Online Pharmacy &nbsp;2.5 Arthralgia Treatment Sales by Application &nbsp;2.5.1 Global Arthralgia Treatment Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Arthralgia Treatment Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Arthralgia Treatment Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Arthralgia Treatment Breakdown Data by Company &nbsp;3.1.1 Global Arthralgia Treatment Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Arthralgia Treatment Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Arthralgia Treatment Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Arthralgia Treatment Revenue by Company (2020-2025) &nbsp;3.2.2 Global Arthralgia Treatment Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Arthralgia Treatment Sale Price by Company &nbsp;3.4 Key Manufacturers Arthralgia Treatment Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Arthralgia Treatment Product Location Distribution &nbsp;3.4.2 Players Arthralgia Treatment Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Arthralgia Treatment by Geographic Region &nbsp;4.1 World Historic Arthralgia Treatment Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Arthralgia Treatment Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Arthralgia Treatment Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Arthralgia Treatment Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Arthralgia Treatment Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Arthralgia Treatment Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Arthralgia Treatment Sales Growth &nbsp;4.4 APAC Arthralgia Treatment Sales Growth &nbsp;4.5 Europe Arthralgia Treatment Sales Growth &nbsp;4.6 Middle East & Africa Arthralgia Treatment Sales Growth 5 Americas &nbsp;5.1 Americas Arthralgia Treatment Sales by Country &nbsp;5.1.1 Americas Arthralgia Treatment Sales by Country (2020-2025) &nbsp;5.1.2 Americas Arthralgia Treatment Revenue by Country (2020-2025) &nbsp;5.2 Americas Arthralgia Treatment Sales by Type (2020-2025) &nbsp;5.3 Americas Arthralgia Treatment Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Arthralgia Treatment Sales by Region &nbsp;6.1.1 APAC Arthralgia Treatment Sales by Region (2020-2025) &nbsp;6.1.2 APAC Arthralgia Treatment Revenue by Region (2020-2025) &nbsp;6.2 APAC Arthralgia Treatment Sales by Type (2020-2025) &nbsp;6.3 APAC Arthralgia Treatment Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Arthralgia Treatment by Country &nbsp;7.1.1 Europe Arthralgia Treatment Sales by Country (2020-2025) &nbsp;7.1.2 Europe Arthralgia Treatment Revenue by Country (2020-2025) &nbsp;7.2 Europe Arthralgia Treatment Sales by Type (2020-2025) &nbsp;7.3 Europe Arthralgia Treatment Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Arthralgia Treatment by Country &nbsp;8.1.1 Middle East & Africa Arthralgia Treatment Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Arthralgia Treatment Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Arthralgia Treatment Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Arthralgia Treatment Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Arthralgia Treatment &nbsp;10.3 Manufacturing Process Analysis of Arthralgia Treatment &nbsp;10.4 Industry Chain Structure of Arthralgia Treatment 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Arthralgia Treatment Distributors &nbsp;11.3 Arthralgia Treatment Customer 12 World Forecast Review for Arthralgia Treatment by Geographic Region &nbsp;12.1 Global Arthralgia Treatment Market Size Forecast by Region &nbsp;12.1.1 Global Arthralgia Treatment Forecast by Region (2026-2031) &nbsp;12.1.2 Global Arthralgia Treatment Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Arthralgia Treatment Forecast by Type (2026-2031) &nbsp;12.7 Global Arthralgia Treatment Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Pfizer Inc. &nbsp;13.1.1 Pfizer Inc. Company Information &nbsp;13.1.2 Pfizer Inc. Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.1.3 Pfizer Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Pfizer Inc. Main Business Overview &nbsp;13.1.5 Pfizer Inc. Latest Developments &nbsp;13.2 GSK Plc &nbsp;13.2.1 GSK Plc Company Information &nbsp;13.2.2 GSK Plc Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.2.3 GSK Plc Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 GSK Plc Main Business Overview &nbsp;13.2.5 GSK Plc Latest Developments &nbsp;13.3 Novartis AG &nbsp;13.3.1 Novartis AG Company Information &nbsp;13.3.2 Novartis AG Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.3.3 Novartis AG Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Novartis AG Main Business Overview &nbsp;13.3.5 Novartis AG Latest Developments &nbsp;13.4 Mylan N.V. &nbsp;13.4.1 Mylan N.V. Company Information &nbsp;13.4.2 Mylan N.V. Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.4.3 Mylan N.V. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Mylan N.V. Main Business Overview &nbsp;13.4.5 Mylan N.V. Latest Developments &nbsp;13.5 Teva Pharmaceutical Industries Ltd. &nbsp;13.5.1 Teva Pharmaceutical Industries Ltd. Company Information &nbsp;13.5.2 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.5.3 Teva Pharmaceutical Industries Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Teva Pharmaceutical Industries Ltd. Main Business Overview &nbsp;13.5.5 Teva Pharmaceutical Industries Ltd. Latest Developments &nbsp;13.6 Sanofi S.A &nbsp;13.6.1 Sanofi S.A Company Information &nbsp;13.6.2 Sanofi S.A Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.6.3 Sanofi S.A Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Sanofi S.A Main Business Overview &nbsp;13.6.5 Sanofi S.A Latest Developments &nbsp;13.7 Boehringer Ingelheim International GmbH &nbsp;13.7.1 Boehringer Ingelheim International GmbH Company Information &nbsp;13.7.2 Boehringer Ingelheim International GmbH Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.7.3 Boehringer Ingelheim International GmbH Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Boehringer Ingelheim International GmbH Main Business Overview &nbsp;13.7.5 Boehringer Ingelheim International GmbH Latest Developments &nbsp;13.8 AstraZeneca &nbsp;13.8.1 AstraZeneca Company Information &nbsp;13.8.2 AstraZeneca Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.8.3 AstraZeneca Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 AstraZeneca Main Business Overview &nbsp;13.8.5 AstraZeneca Latest Developments &nbsp;13.9 Johnson & Johnson Private Limited &nbsp;13.9.1 Johnson & Johnson Private Limited Company Information &nbsp;13.9.2 Johnson & Johnson Private Limited Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.9.3 Johnson & Johnson Private Limited Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Johnson & Johnson Private Limited Main Business Overview &nbsp;13.9.5 Johnson & Johnson Private Limited Latest Developments &nbsp;13.10 Merck & Co., Inc. &nbsp;13.10.1 Merck & Co., Inc. Company Information &nbsp;13.10.2 Merck & Co., Inc. Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.10.3 Merck & Co., Inc. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Merck & Co., Inc. Main Business Overview &nbsp;13.10.5 Merck & Co., Inc. Latest Developments &nbsp;13.11 Hoffmann-La Roche Ltd. &nbsp;13.11.1 Hoffmann-La Roche Ltd. Company Information &nbsp;13.11.2 Hoffmann-La Roche Ltd. Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.11.3 Hoffmann-La Roche Ltd. Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Hoffmann-La Roche Ltd. Main Business Overview &nbsp;13.11.5 Hoffmann-La Roche Ltd. Latest Developments &nbsp;13.12 Bristol-Myers Squibb Company &nbsp;13.12.1 Bristol-Myers Squibb Company Company Information &nbsp;13.12.2 Bristol-Myers Squibb Company Arthralgia Treatment Product Portfolios and Specifications &nbsp;13.12.3 Bristol-Myers Squibb Company Arthralgia Treatment Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Bristol-Myers Squibb Company Main Business Overview &nbsp;13.12.5 Bristol-Myers Squibb Company Latest Developments 14 Research Findings and Conclusion

Report	Global Arthralgia Treatment Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50412

Buyer Information

Order Summary